Paolo Caliceti received his M.Sc. in Pharmaceutical Chemistry and Technology in 1984 and Ph.D. in Pharmaceutical Sciences in 1989 from the University of Padova (Italy). IN 1986-987 he has been visiting scientist at the Endocrinology Division of NIH in Bethesda, in 1990 at the Enzyme Engineering Dept. - Inst. Experimental Cardiology Research Center of Academy of Sciences in Moscow, and in 1994 at SmithKline Beecham Pharmaceuticals in King of Prussia (USA). In 1998, he became Assistant Professor in Applied Pharmaceutical Technology at the University of Padua, where he was promoted to Associate Professor in 1989 and Full Professor in 2002. From 2015 to 2019, Paolo Caliceti has served as Head of the Pharmaceutical and Pharmacological Department at the University of Padua. From 2008 to 2014, he was President of the CRS Italy Local Chapter and from 2009 to 2012 served as the Coordinator of CRS Local Chapters. Since 2021, he is President of the Italian Society of Drug Delivery (ADRITELF and Divisione di Tecnologia Farmaceutica – SCI). He is an active member of international drug delivery community.
Paolo Caliceti is a member of Editorial Boards of multiple pharmaceutical journals and, since 2018, he is serving as Associate Editor of the Journal of Controlled Release. He has been a member of national and international review panels for research projects, including the European Research Council and the Innovative Medicine Initiative, and as consultant with Italian and International pharmaceutical companies.
His research activity is related to the synthesis, characterization and preclinical validation of targeted drug delivery systems to improve drug bioavailability, stability, local delivery, active and passive targeting, and controlled delivery. The activities of the Caliceti ‘s research groups are mostly centered around protein PEGylation; nano- and micro-particle development by supercritical techniques; stimuli sensitive and targeted polymer bioconjugates, gold nanoparticles, micelles, liposomes and polymersomes, supramolecular assemblies for protein and oligonucleotide delivery.
Paolo Caliceti has co-authored over 180 papers and is the co-inventor of 17 patents.
